November 20th 2024
Melt Pharmaceuticals announced positive results from its Phase 3 study of MELT-300, a non-IV, non-opioid tablet for procedural sedation during cataract surgery. The results support a regulatory submission, with potential to revolutionize sedation practices in various medical specialties.
(CME) Community Practice Connections™: A Closer Look at Neurotrophic Keratitis—Ensuring Timely Diagnosis and Taking Early Action
View More
Community Practice Connections™: Mastering the Multidisciplinary Management of Glaucoma—Understanding Advances in the Spectrum of Treatment Innovation (CME/CNE Credit)
View More
Community Practice Connections™: Mastering the Multidisciplinary Management of Glaucoma—Understanding Advances in the Spectrum of Treatment Innovation (COPE Credit)
View More
(COPE) Community Practice Connections™: A Closer Look at Neurotrophic Keratitis—Ensuring Timely Diagnosis and Taking Early Action
View More
Advancing Treatment in Neovascular Retinal Disease with Novel Therapies: Insights and Strategies from Latest Real-World and Clinical Data
View More
Rapid Reviews in Retina™: Emerging Updates from Fall 2023 – Addressing the Wealth of New Data in Treatments for nAMD and DME
View More
(CME) Stratifying the Spectrum of Care in Glaucoma Management – Advancing Treatment with a Vast Armamentarium
View More
(CME) Community Practice Connections™: Optimizing Multidisciplinary Care for nAMD & DME – Expert Perspectives with New Dosing Strategies on the Horizon
View More
(COPE) Community Practice Connections™: Optimizing Multidisciplinary Care for nAMD & DME – Expert Perspectives with New Dosing Strategies on the Horizon
View More
(CME) Community Practice Connections™: Advancing Management Strategies in Geographic Atrophy– Mapping Out the Continuum of Care in a New Era of Transformative Treatment
View More
(COPE) Community Practice Connections™: Advancing Management Strategies in Geographic Atrophy– Mapping Out the Continuum of Care in a New Era of Transformative Treatment
View More
(CME) Key Advances in Cataract Surgery – Applications for New Technologies in an Ever-Changing Landscape
View More
(COPE) Key Advances in Cataract Surgery – Applications for New Technologies in an Ever-Changing Landscape
View More
Managing Ocular Toxicities in Patients With Cancer: Understanding ADCs and the ECP’s Role in Collaborative Management Therapy on the Horizon (CME Credit)
View More
Managing Ocular Toxicities in Patients With Cancer: Understanding ADCs and the ECP’s Role in Collaborative Management Therapy on the Horizon (COPE Credit)
View More
SimulatED™: Applying Advanced Treatment for nAMD & DME - Simulating New Strategies for Clinical Management
View More
EnVision Summit
February 14-17, 2025
Register Now!
Revolutionizing nAMD and DME Management: Collaborative Strategies in the Age of Durable Treatments
March 16, 2025
Register Now!
Navigating the Advances in the Treatment of Geographic Atrophy: Updates and Strategies for Managed Care
View More
Surv.AI Says: Real-World Insights Into Patient Burden & Evolving Strategies in nAMD and DME (CME Credit)
View More
Surv.AI Says: Real-World Insights into Patient Burden & Evolving Strategies in nAMD and DME (COPE Credit)
View More
Community Practice Connections™: Optimizing Outcomes in Glaucoma Management - Applying Evidence to Practice with a Multitude of Treatment Options (CME Track)
View More
Community Practice Connections™: Mastering the New Treatment Paradigm in Geographic Atrophy – From Detection to Intervention (CME Track)
View More
Assessing the Evidence for Extending Treatment Intervals in nAMD and DME Management – Expert Insights into Innovative Approaches (CME Track)
View More
Assessing the Evidence for Extending Treatment Intervals in nAMD and DME Management – Expert Insights into Innovative Approaches (COPE Track)
View More
Community Practice Connections™: Optimizing Outcomes in Glaucoma Management - Applying Evidence to Practice with a Multitude of Treatment Options (COPE Track)
View More
Reimagining Dry Eye Disease: Delineating the Role of Evaporation From Inflammation and Insights Into Optimizing Treatment (CME Track)
View More
Reimagining Dry Eye Disease: Delineating the Role of Evaporation From Inflammation and Insights Into Optimizing Treatment (COPE Track)
View More
Uncovering Neurotrophic Keratitis: Exploring Hidden Manifestations and Key Patient Demographics (CME Track)
View More
Uncovering Neurotrophic Keratitis: Exploring Hidden Manifestations and Key Patient Demographics (COPE Track)
View More
Better outcomes possible for keratoconus patents
February 15th 2007London-The visual outcomes of patients with keratoconus were improved when using a femtosecond laser (IntraLase, Advanced Medical Optics Inc.) to create the channels for implantation of intrastromal corneal implants (Intacs, Addition Technology Inc.), according to Sheraz Daya, MD, FACS.
Read More
Laser channel dissection surpasses mechanical approach
February 15th 2007Las Vegas-The use of a femtosecond laser (IntraLase, Advanced Medical Optics) to create channels for placement of corneal implants (Intacs, Addition Technology Inc.) seems to provide better visual and refractive improvements compared with mechanical implantation of the segments, according to Aylin Ertan, MD.
Read More
RLE accompanied by ethical considerations
February 1st 2007Las Vegas-Refractive lens exchange (RLE) is associated with an increased burden of informed consent disclosure because of the complex issues, both current and future, accompanying that procedure, said Douglas D. Koch, MD, at the Refractive Sur-gery Subspecialty Day during the American Academy of Ophthalmology annual meeting.
Read More
SLT comparable with medical therapy for open-angle glaucoma
January 15th 2007Las Vegas-Selective laser trabeculoplasty (SLT) is comparable to medical treatment as the initial therapy for open-angle glaucoma (OAG) or ocular hypertension, according to results of a study reported by L. Jay Katz, MD, and colleagues here at the American Academy of Ophthalmology annual meeting.
Read More
Pioneer of ophthalmic plastic surgery followed his calling
January 15th 2007Editor's Note: During the time I was a resident at Manhattan Eye, Ear and Throat Hospital (1969-1972), I had the good fortune to work with Byron Capleese Smith, MD. Those who knew him will never forget him, and those who were not able to know him will gain a small glimpse of his persona and his contributions, as written by Christopher Teng, MD. -Norman Medow, MD
Read More
Shallow corneal flaps offer biomechanical stability
January 1st 2007London-Thin, shallow corneal flaps of approximately 80 to 90 ?m created with an IntraLase femtosecond laser (IntraLase Corp.) may produce the best results in refractive surgery, effectively eliminating pain and haze while producing long-term visual stability, said John Marshall, PhD, in a keynote address during a session on femtosecond lasers here at the XXIV Congress of the European Society of Cataract and Refractive Surgeons (ESCRS).
Read More
Intracameral entry of antibiotic ointment seen after cataract surgery
January 1st 2007A 59-year-old male was referred for decreased vision and glare in his right eye 7 days after uneventful clear corneal (CC) phacoemulsification with IOL implantation. On postoperative day 1, his visual acuity was 20/25 in the affected eye. The anterior chamber reaction revealed 1+ cell and flare and the IOL was clear.
Read More
Surgical technique for facial palsy provides good outcomes
December 15th 2006Austin, TX-A new surgical technique addresses the cosmetic concerns of patients with facial palsy and provides them the eye protection that they need, said Sheri L. De Martel?re, MD, an oculoplastic surgeon in private practice in Austin, TX.
Read More
Scleral spacing procedures investigated for presbyopia
December 15th 2006New York-The use of a scleral spacing procedure using PreView Scleral Implants (Refocus Group Inc.) appears to improve the technique to correct presbyopia. This revised technique seems to be a safe and effective method of improving near visual acuity without affecting distance visual acuity in emmetropic presbyopia, according to Barrie D. Soloway, MD, FACS.
Read More
SOLX creates GMS certification program
December 5th 2006Boston-SOLX, the glaucoma division of OccuLogix Inc., has begun an international program to train and certify ophthalmologists in Europe and the Middle East in surgical implantation procedures using the company’s Gold Micro-Shunt (GMS) products to treat patients with glaucoma.
Read More
Vitamin A deficiency returns to an unsuspecting audience
December 1st 2006Houston-Intestinal surgeries-such as gastric bypass, resections of the large and small bowel, and gallbladder removal-may interfere with the intestine's ability to absorb vitamin A, resulting in the potential for severe deficiencies and compromised vision.
Read More
Better PK results foreseen with custom overlapping incision shapes
November 15th 2006London- One of the most revolutionary technological changes in corneal transplant surgery in decades is beginning to hit clinics around the world. A software and hardware upgrade for the femtosecond laser (IntraLase FS, IntraLase Corp.) has been released to help surgeons design custom incision shapes that improve surgical precision and promote faster healing.
Read More
Many factors affect wound healing after epi-LASIK
November 15th 2006Many factors play a role in wound healing after epi-LASIK. For example, use of nonsteroidal anti-inflammatory drugs (NSAIDs) after surgery, advanced age, and a compromised tear film have been associated with delayed wound healing, whereas younger age, healthy tear film, and certain nutritional supplements have been associated with rapid wound healing.
Read More
Cataract surgeons debate risks, benefits of blue-light-filtering IOLs
November 13th 2006Blue-light-filtering IOLs provide protection against potential blue light toxicity without significantly affecting clinical functioning of recipients, said James D. McCulley, MD, during a spotlight session on pseudophakic IOLs at the annual meeting of the American Academy of Ophthalmology.
Read More
Gold Micro-Shunt offers good IOP reduction without bleb
November 11th 2006The SOLX Gold Micro-Shunt (GMS, OccuLogix) is a novel approach to treating increased IOP in patients with open-angle glaucoma that does not respond to other therapies and is a good alternative to trabeculectomy, according to Shlomo Melamed, MD, an investigator based in Tel Aviv, Israel.
Read More
Gold Micro-Shunt offers good IOP reduction without bleb
November 11th 2006The SOLX Gold Micro-Shunt (GMS, OccuLogix) is a novel approach to treating increased IOP in patients with open-angle glaucoma that does not respond to other therapies and is a good alternative to trabeculectomy, according to Shlomo Melamed, MD, an investigator based in Tel Aviv, Israel.
Read More
Sealed capsule irrigation device helps prevent PCO development in small eyes
November 1st 2006Stockholm, Sweden-The Perfect Capsule (Milvella), a sealed capsule irrigation device, seems to be very useful in very small eyes for preventing posterior capsular opacification (PCO), according to Maria Kugelberg, MD, PhD.
Read More
Foldable phakic IOL corrects myopia
November 1st 2006Maastricht, The Netherlands-Preliminary results with the foldable iris-claw myopic phakic IOL (Artiflex, Ophtec) indicate it has a similar safety index when compared with the original polymethylmethacrylate (PMMA) model (Artisan, Ophtec), but is associated with less early induced refractive astigmatism, which results in a better efficacy index initially and shorter visual recovery curve, said Rudy M.M.A. Nuijts, MD, PhD.
Read More
Good functional vision in presbyopic patients is attainable
November 1st 2006Since our practice began offering presbyopia-correcting IOLs, we have implanted 450 of them. One in five of our cataract and refractive lens exchange patients chooses one of these new lenses. The AcrySof ReSTOR lens (Alcon Laboratories) accounts for 80% of our presbyopia-correcting implants, while the ReZoom (Advanced Medical Optics) and the crystalens (eyeonics) together represent 20%.
Read More